Webcast Educates Physicians on Aortic Aneurysms

Webcast Educates Physicians on Aortic Aneurysms.  Albert Einstein died on April 18, 1955 of a leaking abdominal aortic aneurysm.   Sixty years after Einstein’s death, we have a lot more options for managing aortic aneurysms than wrapping them with cellophane and the treatment has drastically changed just in the past decade.  On today’s CME Webcast, with Dr. Jim Allen, to tell us all about abdominal aortic aneurysms and the current state of the art in treating them is vascular surgeon and Assistant Professor of Surgery at the Ohio State University, Dr. Michael Go.  Also joining us in the studio from the OSU Division of Vascular Surgery, we have Assistant Professor of Surgery is Dr. Mounir Haurani.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the pathophysiology and natural history of AAA; DIAGNOSE AAA.

You’ll also learn about the following:

• Clinical presentation of abdominal aortic aneurysms
• Changes in surgical outcomes for aortic aneurysm repair
• Initial management of the ruptured abdominal aortic aneurysm
• Surgical approach to the ruptured abdominal aortic aneurysm
• Infrarenal versus suprarenal abdominal aortic aneurysms
• Late complications of endovascular graft repair
• Preventing enlargement of the aneurysm
• Choosing a stent graft

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Understand Resistant Hypertension with On-line Education

Understand Resistant Hypertension with On-line Education. On this MedNet21 CME Webcast, we’re going to hear more about resistant hypertension: what some of the causes are, what the pharmacologic approach is, and how a new endovascular procedure might hold the promise of improved blood pressure control for these patients in the future.  Let me welcome today’s guests in the studio with Dr. Jim Allen.  First, we have from the Division of Nephrology, Assistant Professor of Internal Medicine Dr. Christopher Valentine. Joining him from the Division of Cardiovascular Medicine is Associate Professor of Internal Medicine and the Medical Director of the Richard M. Ross Heart Hospital at the Wexner Medical Center, Dr. Ernest Mazzaferri.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW secondary causes of hypertension; Discuss therapy of resistant hypertension; and RECOGNIZE the Role of Sympathetic N.S. in HTN.

You’ll also learn about the following:

• Epidemiology of resistant hypertension
• Consequences of inadequately treated hypertension
• The future of catheter-based renal denervation
• Patient selection for renal denervation
• An On-line Webcast about Secondary Causes of Hypertension
• Lab testing of patients with resistant hypertension

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.